The Effect of Different Ketone Supplements on β-OHB and Blood Glucose in Healthy Individuals
- Conditions
- Blood GlucoseKetosis
- Interventions
- Dietary Supplement: 1,3-ButanediolDietary Supplement: (R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoesterDietary Supplement: Beta-hydroxybutyric acid
- Registration Number
- NCT05273411
- Lead Sponsor
- University of British Columbia
- Brief Summary
Ketone bodies are a fuel source and signaling molecule that are produced by your body during prolonged fasting or if you consistently eat at low-carbohydrate diet. Blood ketones can be used as a source of energy during fasting and are used by your brain as an alternative source of fuel to glucose. Previous studies have found that ketones, when consumed in form of a supplement drink, can increase blood ketone levels and lower blood glucose, the amount of sugar in your blood. This is of potential interest for individuals with high blood sugar, such as people living with type 2 diabetes. However, there are different types of ketone supplements that differ in how they are metabolized in the body. Little is known about how these supplements affect blood ketone and blood glucose levels. The main objective of this study is to determine the effect of three different ketone supplements on blood ketones and blood glucose. The results of this pilot study will be used to guide future research for larger and more extensive studies on ketone supplements.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
- over the age of 18;
- able to fast overnight
- being a competitive endurance athlete;
- following a ketogenic diet, low-calorie diet, periodic fasting regimen, or regularly consuming ketogenic supplements;
- being unable to travel to and from the university;
- being unable to follow the diet instructions;
- being pregnant or planning to become pregnant during the study;
- having been diagnosed with a chronic disorder of glucose or fat metabolism, including type 2 diabetes, chronic pancreatitis, or gallbladder disease;
- being unable to read or communicate in English
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description 1,3-Butanediol 1,3-Butanediol 1 x 35 mL (R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoester (R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoester 1 x 20 mL Beta-hydroxybutyric acid Beta-hydroxybutyric acid 1 x 237 mL
- Primary Outcome Measures
Name Time Method Blood Beta-hydroxybutyrate 240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation) Are under the curve (AUC) across 240 minutes after supplement consumption (assessed at baseline and 15, 30, 60, 90, 120, 180, and 240 post-supplementation)
- Secondary Outcome Measures
Name Time Method Blood Pressure 240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation) Change over time
Supplement Acceptability & Taste 240 minutes post-supplementation Questionnaire
Gastrointestinal Discomfort 60 minutes post-supplementation Questionnaire
Blood Glucose 240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation) Area under the curve (AUC)
Heart Rate 240 minutes (assessed at baseline and 15, 30, 60, 90, 120, 180, 240 minutes post-supplementation) Change over time
Hunger & Fullness 240 minutes post-supplementation Questionnaire
Trial Locations
- Locations (1)
University of British Columbia Okanagan
🇨🇦Kelowna, British Columbia, Canada